Anika Therapeutics, Inc.
ANIK· Nasdaq
ANIKAnika Therapeutics, Inc.
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Revenue | $22.90M | $26.28M | $20.83M | $19.62M |
| Net Income | $7.82M | $9.30M | $5.89M | $3.74M |
| EPS Diluted | $0.51 |
Anika Therapeutics, Inc. · CIK 898437 · Engraved from SEC EDGAR
| $0.60 |
| $0.40 |
| $0.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
